Association between antidepressant use and delirium in older adults: an analysis of the World Health Organization's global pharmacovigilance database

被引:0
|
作者
Minoc, Elise-Marie [1 ,2 ]
Villain, Cedric [1 ,2 ]
Benbrika, Soumia [5 ,7 ]
Chretien, Basile [3 ]
Descatoire, Pablo [1 ]
Heraudeau, Marie [2 ]
Sassier, Marion [3 ]
Pierre, Melissa [1 ,7 ]
Martinaud, Olivier [6 ,7 ]
Dolladille, Charles [3 ,4 ]
Lelong-Boulouard, Veronique [2 ,3 ]
机构
[1] CHU Caen, Geriatr Dept, Ave Cote De Nacre, F-14000 Caen, France
[2] Normandie Univ, INSERM, UNICAEN, COMETE, F-14000 Caen, France
[3] CHU Caen, Pharmacol Dept, F-14000 Caen, France
[4] UNICAEN, Normandie Univ, INSERM, U1086,ANTICIPE, F-14000 Caen, France
[5] CHU Caen, Psychiat Dept, F-14000 Caen, France
[6] CHU Caen, Neurol Dept, F-14000 Caen, France
[7] UNICAEN, Normandie Univ, INSERM, UMR 1077, F-14000 Caen, France
关键词
Antidepressants; Delirium; Older adults; DOUBLE-BLIND; IN-VITRO; CITALOPRAM; SYMPTOMS; DRUG; DEPRESSION; DOXEPIN; VIVO; RISK;
D O I
10.1186/s12877-024-05022-0
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
BackgroundPsychoactive drugs frequently cause delirium adverse events in older adults. However, few data on the relationship between antidepressants and delirium are available. Here, we investigated the association between antidepressant prescription and pharmacovigilance reports of delirium in older adults.MethodsUsing the World Health Organization's VigiBase (R) global pharmacovigilance database from 1967 to 2022, we performed a disproportionality analysis in order to probe the putative associations between each antidepressant class (non-selective monoamine reuptake inhibitors (NSMRIs), selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), monoamine oxidase inhibitors (MAOIs), alpha-2-adrenergic receptor antagonists, and other antidepressants) and reports of delirium in people aged 65 or over. We calculated the reporting odds ratios (r-OR) and their 95% confidence interval ([95%CI]) with logistic regression models before and after adjustment for confounding factors. Secondary analyses were performed for each drug and within each class by age group (65-74, and 75 and over). We also studied the reports of concomitant delirium and hyponatremia.ResultsOur main analysis included 87,524 cases of delirium. After adjustment for confounders, a significant association was found between delirium and all antidepressant classes other than SNRIs. Intraclass disparities were found for the association between the most frequently prescribed antidepressants and reports of delirium. An elevated risk of reports of concomitant delirium and hyponatremia was found for SSRIs (4.46 [4.01-4.96]), SNRIs (1.25 [1.07-1.46]), MAOIs (1.72 [1.41-2.09]), and the "other antidepressants" class (1.47 [1.30-1.65]).ConclusionsThere was a significant association between reports of delirium and antidepressant classes (other than SNRIs). However, this association varied from one drug to another within a given antidepressant class. Moreover, this association could not always be explained by antidepressant-induced hyponatremia.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] The association between antidepressant use and hemoglobin A1C in older adults
    Kammer, Jamie
    Hosler, Akiko S.
    Leckman-Westin, Emily
    DiRienzo, A. Gregory
    GERIATRIC NURSING, 2017, 38 (02) : 141 - 145
  • [2] Drugs and bruxism: A study in the World Health Organization's pharmacovigilance database
    Montastruc, Jean-Louis
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (12) : 3765 - 3768
  • [3] Drugs associated with epidermal necrolysis in children: A World Health Organization pharmacovigilance database analysis
    Bataille, Pauline
    Lebrun-Vignes, Benedicte
    Bettuzzi, Thomas
    Ingen-Housz-Oro, Saskia
    Hadj-Rabia, Smail
    Welfringer-Morin, Anne
    Bodemer, Christine
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024, 38 (09) : 1791 - 1798
  • [4] Association between first-line antidepressant use and risk of dementia in older adults: a retrospective cohort study
    Wang, Grace Hsin-Min
    Chen, Wei-Han
    Chang, Shao-Hsuan
    Zhang, Tianxiao
    Shao, Hui
    Guo, Jingchuan
    Lo-Ciganic, Wei-Hsuan
    BMC GERIATRICS, 2023, 23 (01)
  • [5] Association between first-line antidepressant use and risk of dementia in older adults: a retrospective cohort study
    Grace Hsin-Min Wang
    Wei-Han Chen
    Shao-Hsuan Chang
    Tianxiao Zhang
    Hui Shao
    Jingchuan Guo
    Wei-Hsuan Lo-Ciganic
    BMC Geriatrics, 23
  • [6] Adverse reactions of PDE5 inhibitors: An analysis of the World Health Organization pharmacovigilance database
    Lui, Jason L.
    Shaw, Nathan M.
    Abbasi, Behzad
    Hakam, Nizar
    Breyer, Benjamin N.
    ANDROLOGY, 2023, : 1408 - 1417
  • [7] Association of Cerebral Venous Thrombosis with mRNA COVID-19 Vaccines: A Disproportionality Analysis of the World Health Organization Pharmacovigilance Database
    Park, Jin
    Park, Moo-Seok
    Kim, Hyung Jun
    Song, Tae-Jin
    VACCINES, 2022, 10 (05)
  • [8] The association between delirium and falls in older adults in the community: a systematic review and meta-analysis
    Eost-Telling, Charlotte
    Mcnally, Lucy
    Yang, Yang
    Shi, Chunhu
    Norman, Gill
    Ahmed, Saima
    Poku, Brenda
    Money, Annemarie
    Hawley-Hague, Helen
    Todd, Chris J.
    Shenkin, Susan Deborah
    Vardy, Emma R. L. C.
    AGE AND AGEING, 2024, 53 (12)
  • [9] A replication study using the World Health Organization pharmacovigilance database (VigiBase®) to evaluate whether an association between ketamine and esketamine and alcohol and substance misuse exists
    Kwan, Angela T. H.
    Rosenblat, Joshua D.
    Mansur, Rodrigo B.
    Rhee, Taeho Greg
    Teopiz, Kayla
    Le, Gai Han
    Wong, Sabrina
    Cao, Bing
    Ho, Roger
    McIntyre, Roger S.
    JOURNAL OF AFFECTIVE DISORDERS, 2024, 363 : 589 - 594
  • [10] Associations between osteoporosis and drug exposure: A post-marketing study of the World Health Organization pharmacovigilance database (VigiBase®)
    Batteux, B.
    Bennis, Y.
    Bodeau, S.
    Masmoudi, K.
    Hurtel-Lemaire, A. S.
    Kamel, S.
    Gras-Champel, V.
    Liabeuf, S.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2022, 36 : 159 - 159